Skip to content

The Effect of Contrast Agent on Endothelial Function in Healthy Men

The Effect of Contrast Agent on Endothelial Function in Healthy Men

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01895699
Enrollment
60
Registered
2013-07-10
Start date
2013-07-31
Completion date
2015-07-31
Last updated
2015-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast Agent, Endothelial Function, Cytokines, Apoptosis of Endothelial Progenitor Cell, Free Radical, Alpha-lipoic Acid

Keywords

Contrast agent, endothelium, Free radical, Alpha lipoic acid

Brief summary

Contrast medium is essential for diagnosis of many diseases. However, recent studies showed that contrast agents can induce renal injury and is associated with poor long-term clinical outcome, especially in diabetes. To date, no data are available on the relationship between contrast medium and endothelial function. Endothelial dysfunction is known to precede atherosclerosis and is considered a risk marker for future development of cardiovascular disease. Therefore, we hypothesized that contrast agents may induce endothelial dysfunction in healthy men. In addition, we hypothesized that contrast induced endothelial dysfunction via free radicals. Thus, we also test alpha-lipoic acid whether or not protect endothelial dysfunction induced by contrast agents.

Interventions

Sponsors

Xiang Guang-da
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy men * 20 yr \< = age \< = 30 yr * 20 \< = body mass index \< = 25

Exclusion criteria

* age \< 20 yr or \> 30 yr * dysfunction for liver, renal, and heart. * other diseases such as diabetes, hypertension, thyroid disease

Design outcomes

Primary

MeasureTime frame
The endothelial dysfunction and the protective role of alpha-lipoic acid6 months

Secondary

MeasureTime frame
The apoptosis of endothelial progenitor cell6 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026